Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsPOC Diagnostics

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1450822

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1450822

Primary Care Point-of-Care (POC) Diagnostics Market by Product Type, End-Users, & Geography (North America, Europe, Asia Pacific, Latin America, & the Middle East & Africa): Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2023-2030

PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7600
PDF (Corporate User License)
USD 10600

Add to Cart

Description

Table of Contents

Persistence Market Research has recently published an in-depth report on the global Primary Care Point-of-Care (POC) Diagnostics Market. This market has witnessed significant growth due to the increasing demand for rapid diagnostic tests in primary care settings, driven by factors such as the rising prevalence of infectious diseases, the growing burden of chronic conditions, and the need for timely and accurate diagnostic solutions to support clinical decision-making. The report highlights the critical role of POC diagnostics in improving patient outcomes, reducing healthcare costs, and enhancing access to diagnostic testing in primary care settings.

The global Primary Care POC Diagnostics market is forecast to expand at a CAGR of 6.4% and thereby increase from US$ 16.3 Bn in 2023 to US$ 25.2 Bn by the end of 2030.

Key Insights:

  • Primary Care POC Diagnostics Market Size (2023E): US$ 16.3 billion
  • Projected Market Value (2030F): US$ 25.2 billion
  • Global Market Growth Rate (CAGR 2023 to 2030): 6.4%
  • Historical Market Growth Rate (CAGR 2018 to 2022): 4.9%

Primary Care POC Diagnostics Market - Report Scope:

The Primary Care POC Diagnostics Market report offers a comprehensive analysis of market dynamics, focusing on historical trends and future projections. POC diagnostics encompass a wide range of rapid tests and handheld devices used for the near-patient testing of various analytes, including infectious agents, biomarkers, and metabolic parameters. These tests play a critical role in primary care settings by providing rapid and actionable diagnostic information to support timely treatment decisions, disease management, and patient counseling. The report delves into various aspects of the primary care POC diagnostics market, including market drivers, technology trends, regulatory landscape, and emerging opportunities shaping the industry landscape.

Market Growth Drivers for Primary Care POC Diagnostics Market:

The increasing demand for rapid diagnostic tests in primary care settings is driven by the need for timely diagnosis and management of acute and chronic conditions, such as infectious diseases, cardiovascular disorders, diabetes, and respiratory illnesses. POC diagnostics offer advantages in terms of rapid turnaround time, ease of use, and accessibility, enabling healthcare providers to obtain diagnostic results quickly and initiate appropriate treatment interventions during patient encounters. Additionally, the decentralization of diagnostic testing from centralized laboratories to point-of-care settings has led to greater adoption of POC diagnostics in primary care clinics, urgent care centers, pharmacies, and community health centers.

Furthermore, technological advancements in POC diagnostic platforms, assay formats, and detection methods have led to the development of next-generation POC devices with improved sensitivity, specificity, and multiplexing capabilities. These advancements enable the detection of multiple analytes from a single sample, enhancing diagnostic accuracy and efficiency in primary care settings. Moreover, the integration of POC diagnostic devices with electronic health records (EHR) systems, telemedicine platforms, and mobile health applications facilitates seamless data capture, analysis, and communication, enabling real-time decision support, remote monitoring, and care coordination in primary care settings.

Market Restraints:

Despite the positive market outlook, the primary care POC diagnostics market faces challenges related to assay performance, quality control, and regulatory compliance. Ensuring the accuracy and reliability of POC diagnostic tests is essential for clinical decision-making and patient management, requiring robust quality control measures, proficiency testing, and adherence to regulatory standards. Manufacturers must address challenges related to assay variability, interferences, and sample matrix effects to ensure consistent performance and reproducibility across different healthcare settings.

Furthermore, regulatory requirements governing the development, validation, and commercialization of POC diagnostic tests vary across different regions, with differences in performance criteria, documentation requirements, and post-market surveillance obligations. Achieving regulatory compliance and securing market approval for POC diagnostic devices can be time-consuming and resource-intensive, leading to delays in product launches and market entry. Additionally, reimbursement policies, coverage determinations, and pricing pressures pose challenges for POC diagnostic manufacturers, as healthcare payers seek evidence of clinical utility, cost-effectiveness, and patient outcomes to justify reimbursement for diagnostic testing in primary care settings.

Market Opportunities:

Amidst the challenges lie opportunities for innovation and market expansion within the primary care POC diagnostics market. Leveraging advancements in microfluidics, biosensors, and digital technologies can lead to the development of next-generation POC diagnostic platforms with enhanced performance, portability, and connectivity features. Integrated POC systems that combine sample preparation, assay detection, and data analysis capabilities offer advantages in terms of workflow efficiency, user convenience, and diagnostic accuracy, enabling comprehensive diagnostic testing at the point of care.

Furthermore, expanding market reach and penetration in emerging economies and underserved regions through strategic partnerships, distribution agreements, and telemedicine initiatives can improve access to POC diagnostic testing and support primary care delivery in resource-limited settings. Investing in research and development, clinical validation studies, and health economics research can help POC diagnostic manufacturers generate evidence of clinical utility, economic value, and patient outcomes, facilitating market adoption and reimbursement decisions. By focusing on user-centric design, interoperability, and data integration, companies can develop POC diagnostic solutions that align with the evolving needs and preferences of primary care providers, patients, and healthcare systems worldwide.

Key Questions Answered in Report::

  • What is the Forecast CAGR of the Primary Care POC Diagnostics Market in 2030?
  • What is the Global Market Size of Primary Care POC Diagnostics as of the End of 2023?
  • Which Region Dominated the Primary Care POC Diagnostics Market in 2023?
  • Who are the Key Players in the Global Primary Care POC Diagnostics Market?
  • Which Primary Care POC Diagnostics Segments Hold the Largest Opportunities for Market Integration?

Competitive Intelligence and Business Strategy:

In navigating the competitive landscape, companies in the Primary Care POC Diagnostics Market must leverage competitive intelligence and strategic business initiatives to differentiate themselves and capitalize on emerging opportunities. Understanding market dynamics, technological trends, and competitor strategies is essential for informed decision-making and market positioning.

Furthermore, investing in research and development, product innovation, and market development strategies can help POC diagnostic manufacturers develop differentiated solutions, expand market reach, and gain competitive advantage in the dynamic primary care POC diagnostics market. By focusing on user-centric design, clinical utility, and cost-effectiveness, companies can strengthen their value proposition, build trust with healthcare providers, and drive market adoption of POC diagnostic testing in primary care settings. Additionally, fostering collaborations with healthcare stakeholders, including clinicians, laboratories, payers, and policymakers, can facilitate market access, reimbursement, and regulatory compliance, supporting sustainable growth and market leadership in the primary care POC diagnostics segment.

Key Companies Profiled:

  • Roche Diagnostics
  • BD Biosciences
  • Danaher Corporation
  • Abbott Laboratories
  • Instrumentation Laboratory
  • bioMerieux
  • Siemens Healthcare
  • Quidel Corporation

Primary Care POC Diagnostics Market Research Segmentation:

Market segmentation based on test type, platform type, application, end-user, and region provides valuable insights into key market segments and regional dynamics, enabling companies to tailor their offerings to specific customer needs and preferences. By understanding the unique requirements of primary care providers, patient populations, and healthcare systems, companies can develop targeted strategies to address market demands effectively, thereby gaining a competitive edge and driving growth in the Primary Care POC Diagnostics Market.

By Product:

  • Glucose Testing
  • Hb1Ac Testing
  • Autoimmune Disease
  • Coagulation
  • Fertility
  • Infectious Diseases
  • Cardiac Markers
  • Thyroid Stimulating Hormone
  • Hematology
  • Primary Care Systems
  • Decentralized Clinical Chemistry
  • Feces
  • Lipid Testing
  • Cancer Marker
  • Blood Gas/Electrolytes
  • Ambulatory Chemistry
  • Drug Abuse Testing
  • Urinalysis

By End User:

  • Pharmacy & Retail Clinics
  • Physician Office
  • Urgent Care Clinics
  • Non-practice Clinics

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa
Show more
Product Code: PMRREP33939

Table of Contents

1. Executive Summary

  • 1.1. Global Primary Care POC Diagnostics Market Snapshot, 2023 and 2030
  • 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Lifecycle Analysis
  • 2.4. Global Primary Care POC Diagnostics Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Primary Care POC Diagnostics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2013-2016
    • 3.2.2. Current Market Size Forecast, 2018-2026
  • 3.3. Global Primary Care POC Diagnostics Market Outlook: Product
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
      • 3.3.3.1. Glucose Testing
      • 3.3.3.2. Hb1Ac Testing
      • 3.3.3.3. Autoimmune Disease
      • 3.3.3.4. Coagulation
      • 3.3.3.5. Fertility
      • 3.3.3.6. Infectious Diseases
      • 3.3.3.7. Cardiac Markers
      • 3.3.3.8. Thyroid Stimulating Hormone
      • 3.3.3.9. Hematology
      • 3.3.3.10. Primary Care Systems
      • 3.3.3.11. Decentralized Clinical Chemistry
      • 3.3.3.12. Feces
      • 3.3.3.13. Lipid Testing
      • 3.3.3.14. Cancer Marker
      • 3.3.3.15. Blood Gas/Electrolytes
      • 3.3.3.16. Ambulatory Chemistry
      • 3.3.3.17. Drug Abuse Testing
      • 3.3.3.18. Urinalysis
  • 3.4. Market Attractiveness Analysis: Product
  • 3.5. Global Primary Care POC Diagnostics Market Outlook: End User
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
      • 3.5.3.1. Pharmacy & Retail Clinics
      • 3.5.3.2. Physician Office
      • 3.5.3.3. Urgent Care Clinics
      • 3.5.3.4. Non-practice Clinics
  • 3.6. Market Attractiveness Analysis: End User

4. Global Primary Care POC Diagnostics Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Global Primary Care POC Diagnostics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 5.3.1. By Country
    • 5.3.2. By Product
    • 5.3.3. By End User
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 5.5.1. Glucose Testing
    • 5.5.2. Hb1Ac Testing
    • 5.5.3. Autoimmune Disease
    • 5.5.4. Coagulation
    • 5.5.5. Fertility
    • 5.5.6. Infectious Diseases
    • 5.5.7. Cardiac Markers
    • 5.5.8. Thyroid Stimulating Hormone
    • 5.5.9. Hematology
    • 5.5.10. Primary Care Systems
    • 5.5.11. Decentralized Clinical Chemistry
    • 5.5.12. Feces
    • 5.5.13. Lipid Testing
    • 5.5.14. Cancer Marker
    • 5.5.15. Blood Gas/Electrolytes
    • 5.5.16. Ambulatory Chemistry
    • 5.5.17. Drug Abuse Testing
    • 5.5.18. Urinalysis
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 5.6.1. Pharmacy & Retail Clinics
    • 5.6.2. Physician Office
    • 5.6.3. Urgent Care Clinics
    • 5.6.4. Non-practice Clinics
  • 5.7. Market Attractiveness Analysis

6. Europe Global Primary Care POC Diagnostics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By End User
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkiye
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 6.5.1. Glucose Testing
    • 6.5.2. Hb1Ac Testing
    • 6.5.3. Autoimmune Disease
    • 6.5.4. Coagulation
    • 6.5.5. Fertility
    • 6.5.6. Infectious Diseases
    • 6.5.7. Cardiac Markers
    • 6.5.8. Thyroid Stimulating Hormone
    • 6.5.9. Hematology
    • 6.5.10. Primary Care Systems
    • 6.5.11. Decentralized Clinical Chemistry
    • 6.5.12. Feces
    • 6.5.13. Lipid Testing
    • 6.5.14. Cancer Marker
    • 6.5.15. Blood Gas/Electrolytes
    • 6.5.16. Ambulatory Chemistry
    • 6.5.17. Drug Abuse Testing
    • 6.5.18. Urinalysis
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 6.6.1. Pharmacy & Retail Clinics
    • 6.6.2. Physician Office
    • 6.6.3. Urgent Care Clinics
    • 6.6.4. Non-practice Clinics
  • 6.7. Market Attractiveness Analysis

7. East Asia Global Primary Care POC Diagnostics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By End User
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 7.5.1. Glucose Testing
    • 7.5.2. Hb1Ac Testing
    • 7.5.3. Autoimmune Disease
    • 7.5.4. Coagulation
    • 7.5.5. Fertility
    • 7.5.6. Infectious Diseases
    • 7.5.7. Cardiac Markers
    • 7.5.8. Thyroid Stimulating Hormone
    • 7.5.9. Hematology
    • 7.5.10. Primary Care Systems
    • 7.5.11. Decentralized Clinical Chemistry
    • 7.5.12. Feces
    • 7.5.13. Lipid Testing
    • 7.5.14. Cancer Marker
    • 7.5.15. Blood Gas/Electrolytes
    • 7.5.16. Ambulatory Chemistry
    • 7.5.17. Drug Abuse Testing
    • 7.5.18. Urinalysis
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 7.6.1. Pharmacy & Retail Clinics
    • 7.6.2. Physician Office
    • 7.6.3. Urgent Care Clinics
    • 7.6.4. Non-practice Clinics
  • 7.7. Market Attractiveness Analysis

8. South Asia & Oceania Global Primary Care POC Diagnostics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By End User
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 8.5.1. Glucose Testing
    • 8.5.2. Hb1Ac Testing
    • 8.5.3. Autoimmune Disease
    • 8.5.4. Coagulation
    • 8.5.5. Fertility
    • 8.5.6. Infectious Diseases
    • 8.5.7. Cardiac Markers
    • 8.5.8. Thyroid Stimulating Hormone
    • 8.5.9. Hematology
    • 8.5.10. Primary Care Systems
    • 8.5.11. Decentralized Clinical Chemistry
    • 8.5.12. Feces
    • 8.5.13. Lipid Testing
    • 8.5.14. Cancer Marker
    • 8.5.15. Blood Gas/Electrolytes
    • 8.5.16. Ambulatory Chemistry
    • 8.5.17. Drug Abuse Testing
    • 8.5.18. Urinalysis
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 8.6.1. Pharmacy & Retail Clinics
    • 8.6.2. Physician Office
    • 8.6.3. Urgent Care Clinics
    • 8.6.4. Non-practice Clinics
  • 8.7. Market Attractiveness Analysis

9. Latin America Global Primary Care POC Diagnostics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By End User
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 9.5.1. Glucose Testing
    • 9.5.2. Hb1Ac Testing
    • 9.5.3. Autoimmune Disease
    • 9.5.4. Coagulation
    • 9.5.5. Fertility
    • 9.5.6. Infectious Diseases
    • 9.5.7. Cardiac Markers
    • 9.5.8. Thyroid Stimulating Hormone
    • 9.5.9. Hematology
    • 9.5.10. Primary Care Systems
    • 9.5.11. Decentralized Clinical Chemistry
    • 9.5.12. Feces
    • 9.5.13. Lipid Testing
    • 9.5.14. Cancer Marker
    • 9.5.15. Blood Gas/Electrolytes
    • 9.5.16. Ambulatory Chemistry
    • 9.5.17. Drug Abuse Testing
    • 9.5.18. Urinalysis
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 9.6.1. Pharmacy & Retail Clinics
    • 9.6.2. Physician Office
    • 9.6.3. Urgent Care Clinics
    • 9.6.4. Non-practice Clinics
  • 9.7. Market Attractiveness Analysis

10. Middle East & Africa Global Primary Care POC Diagnostics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By End User
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 10.5.1. Glucose Testing
    • 10.5.2. Hb1Ac Testing
    • 10.5.3. Autoimmune Disease
    • 10.5.4. Coagulation
    • 10.5.5. Fertility
    • 10.5.6. Infectious Diseases
    • 10.5.7. Cardiac Markers
    • 10.5.8. Thyroid Stimulating Hormone
    • 10.5.9. Hematology
    • 10.5.10. Primary Care Systems
    • 10.5.11. Decentralized Clinical Chemistry
    • 10.5.12. Feces
    • 10.5.13. Lipid Testing
    • 10.5.14. Cancer Marker
    • 10.5.15. Blood Gas/Electrolytes
    • 10.5.16. Ambulatory Chemistry
    • 10.5.17. Drug Abuse Testing
    • 10.5.18. Urinalysis
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 10.6.1. Pharmacy & Retail Clinics
    • 10.6.2. Physician Office
    • 10.6.3. Urgent Care Clinics
    • 10.6.4. Non-practice Clinics
  • 10.7. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2022
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Analog IC
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Roche Diagnostics
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. BD Biosciences
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Danaher Corporation
      • 11.3.3.1. \ Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Abbott Laboratories
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Instrumentation Laboratory
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. bioMerieux
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Siemens Healthcare
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Quidel Corporation
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!